JPWO2023190176A5 - - Google Patents

Info

Publication number
JPWO2023190176A5
JPWO2023190176A5 JP2024512364A JP2024512364A JPWO2023190176A5 JP WO2023190176 A5 JPWO2023190176 A5 JP WO2023190176A5 JP 2024512364 A JP2024512364 A JP 2024512364A JP 2024512364 A JP2024512364 A JP 2024512364A JP WO2023190176 A5 JPWO2023190176 A5 JP WO2023190176A5
Authority
JP
Japan
Prior art keywords
glycero
formula
carbon atoms
group
phosphoglycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024512364A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023190176A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/011850 external-priority patent/WO2023190176A1/ja
Publication of JPWO2023190176A1 publication Critical patent/JPWO2023190176A1/ja
Publication of JPWO2023190176A5 publication Critical patent/JPWO2023190176A5/ja
Pending legal-status Critical Current

Links

JP2024512364A 2022-03-28 2023-03-24 Pending JPWO2023190176A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022051918 2022-03-28
PCT/JP2023/011850 WO2023190176A1 (ja) 2022-03-28 2023-03-24 脾臓組織へ核酸を送達するための脂質ナノ粒子およびこれを用いて脾臓組織へ核酸を送達する方法

Publications (2)

Publication Number Publication Date
JPWO2023190176A1 JPWO2023190176A1 (cg-RX-API-DMAC7.html) 2023-10-05
JPWO2023190176A5 true JPWO2023190176A5 (cg-RX-API-DMAC7.html) 2026-03-19

Family

ID=88201471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024512364A Pending JPWO2023190176A1 (cg-RX-API-DMAC7.html) 2022-03-28 2023-03-24

Country Status (7)

Country Link
US (1) US20260115316A1 (cg-RX-API-DMAC7.html)
EP (1) EP4501360A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023190176A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240163154A (cg-RX-API-DMAC7.html)
CN (1) CN118973614A (cg-RX-API-DMAC7.html)
CA (1) CA3247039A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023190176A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117778533B (zh) * 2023-12-30 2025-01-07 北京剂泰医药科技有限公司 核酸脂质纳米颗粒复合物中核酸的定量检测方法
CN118949071A (zh) * 2024-08-02 2024-11-15 中国科学院动物研究所 一种掺杂金属离子佐剂的脾脏靶向mRNA疫苗及其制备方法与应用
CN120757505B (zh) * 2025-09-08 2025-11-21 联合钠米(天津)科技有限公司 一种二烃基咪唑仿生型脂质化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2702103A1 (en) * 2007-10-12 2009-04-16 Novosom Ag Improvements in or relating to amphotaric liposomes comprising neutral lipids
WO2013073480A1 (ja) 2011-11-18 2013-05-23 日油株式会社 細胞内動態を改善したカチオン性脂質
JP6682856B2 (ja) 2015-01-30 2020-04-15 株式会社三洋物産 遊技機
JP7332478B2 (ja) * 2017-03-15 2023-08-23 モデルナティエックス インコーポレイテッド 脂質ナノ粒子製剤
WO2018237369A2 (en) * 2017-06-23 2018-12-27 Vical Incorporated Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection
CA3094057C (en) 2018-03-27 2025-04-08 Nof Corporation CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS
AU2020232790A1 (en) * 2019-03-06 2021-09-16 Generation Bio Co. Non-active lipid nanoparticles with non-viral, capsid free DNA
CN114929205B (zh) * 2019-09-06 2024-09-03 世代生物公司 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法
WO2021060440A1 (ja) * 2019-09-26 2021-04-01 日油株式会社 脂質ナノ粒子の凍結乾燥組成物
US12534435B2 (en) 2020-03-27 2026-01-27 Generation Bio Co. Lipids and nanoparticle compositions thereof

Similar Documents

Publication Publication Date Title
Heyes et al. Synthesis and characterization of novel poly (ethylene glycol)-lipid conjugates suitable for use in drug delivery
USRE45195E1 (en) Compositions and methods for enhancing contrast in imaging
JP4885715B2 (ja) イリノテカン製剤
AU2009302042A1 (en) Liposomal systems comprising sphingomyelin
CN108024960A (zh) 含有阴离子药物的药物组合物及其制备方法
KR101925507B1 (ko) 조절 약물 방출 리포솜 조성물
US20150283077A1 (en) Controlled release hydrogels
AU2003270102B2 (en) Non-vesicular cationic lipid formulations
US20120003159A1 (en) Compositions and methods for enhancing contrast in imaging
CN113908288A (zh) 一种mRNA递送系统及其制备方法和应用
JP5142313B2 (ja) ポリサルコシン誘導体及びこれを膜構成成分とする薬物担体
KR102911928B1 (ko) 신규 이온화 가능한 지질 및 이를 포함하는 지질나노입자
IL299155B1 (en) Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
WO2025172284A1 (en) Lipids for nanoparticle delivery platform
Seo et al. Positron emission tomography imaging of the stability of Cu-64 labeled dipalmitoyl and distearoyl lipids in liposomes
JP4833836B2 (ja) リポソーム製剤
KR20140036338A (ko) 표적지향형 난용성 약물 전달체
JP2006519262A (ja) リポソームにより誘導される補体活性化の減少のためのリポソーム組成物
WO2002098465A2 (en) Cell penetrating therapeutic agents
CA2595485A1 (en) Liposomal compositions for parenteral delivery of statins
JPWO2005021012A1 (ja) ゲムシタビン封入薬剤担体
WO2019161325A1 (en) Radiation-triggered liposomes
JP2022532075A5 (cg-RX-API-DMAC7.html)
JPWO2023054241A5 (cg-RX-API-DMAC7.html)
WO2023054241A1 (ja) 核酸を脳組織に送達するために用いられる脂質ナノ粒子